Most human trials use the full 43-amino-acid thymosin beta-4 (RGN-259, RGN-137), not the TB-500 fragment
Christopher Shade, PhD, founder and CEO of Quicksilver Scientific, provides key considerations that emerged around bioavailability, formulation quality, and real-world useespecially compared with injectable therapiesin an interview with The American Journal of Managed Care ( AJMC )
Experimental and animal studies demonstrated that the downstream products of vitamin B12 metabolism are increased and oxidative stress, steatosis, and fibrosis develop in the liver in cystathionine -synthase-deficient mice (57)
Key Takeaways Standard dose is 25 units (1mg): drawn from a vial reconstituted with 2.5mL of bacteriostatic water, using an insulin syringe
Profhilo/Sunekos (Skin Boosters)
Prioritize protein: 0.8-1.0g per pound of body weight